Ochsner Health System (OHS) has been a continuously funded CCOP since 1983 serving southern Louisiana and Mississippi.
The specific aims of the Ochsner NCORP Community Site for the initial period will build on the previous goals of the Ochsner CCOP while maintaining alignment with the NCORP programmatic agenda.
The specific aims are as follows: 1. Increase accrual of cancer patients and maintain data quality on prevention and cancer control, treatment and cancer care delivery trials leveraging Ochsner's integrated health network and established tumor specific multidisciplinary groups. 2. Improve availability of clinical trials through the Ochsner NCORP program with special emphasis on women, children, underserved and minority patients. 3. Enhance oncology research staff competence by strategic high quality recruitment, targeted training and retention.
Louisiana's cancer incidence and mortality rates consistently exceed the national average. Due to the high burden of disease, access to clinical trials is imperative in this area. With a medical system of nine hospitals and forty health clinics, Ochsner Health System has the resources to provide Ochsner NCORP with an exceptional ability to offer state of the art clinical trials to the region's diverse population.
|Himelstein, Andrew L; Foster, Jared C; Khatcheressian, James L et al. (2017) Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial. JAMA 317:48-58|
|Katz, Matthew H G; Shi, Qian; Ahmad, Syed A et al. (2016) Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg 151:e161137|